Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview Article

Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review

Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
Michael Nader, ASSOCIATE EDITOR
Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191
Ida Fredriksson
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Venniro
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Reiner
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan J. Chow
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer M. Bossert
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yavin Shaham
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Nader
Roles: ASSOCIATE EDITOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 73 no. 3 1050-1083
DOI 
https://doi.org/10.1124/pharmrev.120.000191
PubMed 
34257149

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online July 13, 2021.

Copyright & Usage 
U.S. Government work not protected by U.S. copyright.

Author Information

  1. Ida Fredriksson,
  2. Marco Venniro,
  3. David J. Reiner,
  4. Jonathan J. Chow,
  5. Jennifer M. Bossert, and
  6. Yavin Shaham
  1. Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, Maryland (I.F., M.V., D.J.R., J.J.C., J.M.B., Y.S.), and Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden
  1. Michael Nader, ASSOCIATE EDITOR
  1. Address correspondence to:
    Ida Fredriksson, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, 251 Bayview Blvd., Baltimore, Maryland 21224. E-mail: ida.fredriksson{at}nih.gov; or Yavin Shaham, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, 251 Bayview Blvd., Baltimore, Maryland 21224. E-mail: yavin.shaham{at}nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2021 to July 2022

AbstractFullPdf
Jul 20215999764
Aug 20213885639
Sep 20213624329
Oct 20214053622
Nov 20212992117
Dec 20211782415
Jan 20222263324
Feb 20222083419
Mar 20222243430
Apr 20221942923
May 20221751614
Jun 2022153188
Jul 2022600

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 73 (3)
Pharmacological Reviews
Vol. 73, Issue 3
1 Jul 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview Article

Relapse after Voluntary Abstinence

Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
Pharmacological Reviews July 1, 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleReview Article

Relapse after Voluntary Abstinence

Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
Pharmacological Reviews July 1, 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. Relapse after Abstinence Induced by Adverse Consequences of Drug Taking and Seeking
    • III. Relapse after Abstinence Induced by Availability of Alternative Nondrug Rewards
    • IV. Conclusions and Clinical Implications
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Molecular Mechanisms of CO-Mediated Signaling
  • Pharmacology of Matrix Metalloproteinases
  • Quantitative Proteomics in Translational Pharmacokinetics
Show more Review article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics